Update information

Update information

October 2018: Links have been added to patient decision aids from some recommendations.

June 2018: This guideline is an update of the NICE guideline on dementia (CG42, published November 2006) and replaces it. It also replaces recommendation 1.3 in the NICE technology appraisal guidance on donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (TA217).

ISBN: 978-1-4731-2978-8

  • National Institute for Health and Care Excellence (NICE)